LATEST: Pfizer submits kids vaccine emergency use authorization request to FDA.
The planned retail cost for the newly approved over-the-counter rapid home COVID-19 test, "Flowflex," will be"less than $10 per test," White House COVID-19 Response Coordinator Jeff Zients said at Wednesday's briefing
ACON, the manufacturers of Flowflex, confirmed with ABC News that the White House's statement is in line with their current estimated pricing. The company told ABC News their goal when creating the at-home test was to make it,"more accessible and more affordable than the other over-the-counter tests in the market."
By comparison the two rapid test kits currently out on the market --Abbott's BinaxNow and Quidel's Quickvue-- each retail for $23.99. Both BinaxNow and Quickvue kits come two tests, so that a person can test themselves twice over the course of a couple days. That means each individual test costs around $12 each.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
COVID-19 live updates: More Americans died of COVID this year than all of 2020LATEST: The Biden administration is set to announce that it's buying another $1 billion of rapid at-home tests, on top of the $2 billion investment in September.
Baca lebih lajut »
Covid-19: Two Covid-related deaths and 1,339 new casesThe total number of coronavirus-linked deaths in NI since the start of the pandemic is 2,575.
Baca lebih lajut »
US child Covid-19 deaths are an 'embarrassment,' FDA vaccines head saysAfter weeks of a troubling Covid-19 surge across the US, infection rates are finally on the decline — but experts say there's still work to be done before the tide can be turned, especially when cases remain exceptionally high among children.
Baca lebih lajut »
Johnson & Johnson Asks FDA to Authorize Covid-19 BoosterJohnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot
Baca lebih lajut »
J&J seeks US clearance for COVID-19 vaccine booster dosesJohnson & Johnson asks the FDA to allow extra shots of its COVID-19 vaccine as the U.S. government moves toward expanding its booster campaign to millions more vaccinated Americans.
Baca lebih lajut »